IV期驱动基因改变非小细胞肺癌的治疗:ASCO动态指南2024.2版
ASCO动态指南针对IV期驱动基因改变非小细胞肺癌的治疗,由常设专家小组持续系统审查文献并定期更新推荐。本版本未在正文中报告具体推荐条款或数值。
要点
- ASCO动态指南由常设专家小组持续系统审查文献并定期更新。
- 本版本未在正文中报告具体推荐条款或数值。
- 动态指南不替代治疗临床医生的独立专业判断。
核心结论
- ASCO动态指南针对IV期驱动基因改变非小细胞肺癌的治疗,由常设专家小组持续系统审查文献并定期更新推荐。
研究设计与样本
- ASCO常设专家小组按ASCO指南方法学手册持续系统审查健康文献并定期更新。
临床怎么用
- 动态指南不替代治疗临床医生的独立专业判断,也不考虑患者个体差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the ASCO Guidelines Methodology Manual. ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines. Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating clinician and do not account for individual variation among patients. See the Appendix for disclaimers and other important information (Appendix 1 and Appendix 2, online only). Updates are published regularly and can be found at https://ascopubs.org/nsclc-da-living-guideline.
引用
- Bazhenova L, Ismaila N, Abu Rous F, et al. Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2. J Clin Oncol. 2024. PMID: 39531596. doi:10.1200/JCO-24-02133
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。